Levobupivacaína Kabi

Levobupivacaine, the active ingredient in Levobupivacaína Kabi, is a local anesthetic presented as a solution for epidural use. It provides regional anesthesia and analgesia for surgical procedures and labor, acting on peripheral nerves to block pain transmission.

GNH USA supplies Levobupivacaína Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide, adhering to stringent quality standards and regulatory requirements. The product is manufactured under GMP conditions and distributed to clinical facilities across multiple continents.

Levobupivacaine is a local anesthetic used in regional anesthesia and epidural analgesia. - Regional anesthesia: provides surgical anesthesia for procedures requiring nerve block. - Epidural analgesia: delivers pain relief during labor and postoperative periods. - Postoperative pain management: extends analgesia after surgery to improve patient comfort.

Levobupivacaine may cause adverse reactions ranging from mild to severe. Common Side Effects: - Hypotension: transient drop in blood pressure. - Bradycardia: slowed heart rate. - Nausea: feeling of sickness. - Injection site pain: discomfort at the site of administration. Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm that can be life‑threatening. - Seizures: uncontrolled electrical activity in the brain. - Respiratory depression: reduced breathing effort requiring support. - Allergic reaction: rash, itching, or anaphylaxis.

Levobupivacaína Kabi should be used with appropriate clinical vigilance. - Dose adjustment: consider patient age, weight, and comorbidities. - Cardiovascular monitoring: observe for hypotension and bradycardia during administration. - CNS monitoring: watch for signs of toxicity such as tinnitus or seizures. - Avoid intravascular injection: aspirate before delivery of the drug. - Pregnancy: use only if the potential benefit justifies the potential risk to the fetus. - Store at room temperature: keep in the original container, protect from light and moisture.

Levobupivacaína Kabi may interact with other medications. Major Interactions (Avoid): - Other local anesthetics: additive toxicity risk. - Class I antiarrhythmics (e.g., quinidine): increased cardiotoxicity. - Beta‑blockers: may exacerbate bradycardia. - Sodium channel blockers (e.g., carbamazepine): enhanced neurotoxicity. Moderate Interactions (Monitor Closely): - Opioids: synergistic respiratory depression. - Sedatives/hypnotics: increased central nervous system depression. - Magnesium sulfate: may potentiate neuromuscular block.